Alluvi Retatrutide 40MG (4×10MG)

£230.00

Alluvi Retatrutide 40mg is an experimental triple-hormone receptor agonist designed to support weight management. It targets GIP, GLP-1, and glucagon receptors and is typically administered once weekly to help promote weight loss.

13 People watching this product now!
Research Purpose
  • Studied for its potential role in triple receptor activation involving GIP, GLP-1, and glucagon receptors.
  • Investigated in laboratory research involving glucose metabolism, energy expenditure, and metabolic regulation.
  • Commonly used in studies of appetite regulation, body composition, and endocrine signaling.
  • Explored for dose-response and long-duration metabolic research using multi-dose delivery systems.
Ingredients
  • Active Compound: Retatrutide
  • Total Strength: 40mg
  • Configuration: 4 × 10mg doses
  • Dosage Form: Pre-filled Multi-Dose Injection Pen
  • Purity: ≥99% (Batch Tested)
  • Excipients: Proprietary sterile research-grade formulation
Packaging Contents
  • 1 × Alluvi Retatrutide 40mg pre-filled multi-dose pen
  • Delivers 4 × 10mg doses
  • Compatible sterile pen needles (where supplied by the manufacturer)
  • Protective pen cap
  • Secure protective packaging
  • Research information leaflet (manufacturer supplied)
Molecular Structure
  • Compound Name: Retatrutide
  • Peptide Sequence: Modified 39-amino acid synthetic peptide with a C20 fatty diacid side chain for extended activity
  • Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈
  • Molecular Weight: 4,731.33 g/mol
  • Chemical Classification: Triple GIP, GLP-1, and Glucagon Receptor Agonist (Tri-Agonist) Synthetic Peptide
Categories: ,